Tools
Tools
Ajibade, PA, Fatokun, AA and Fartisincha, AP (2020) Synthesis, characterization and anti-cancer studies of Mn(II), Cu(II), Zn(II) and Pt(II) dithiocarbamate complexes - crystal structures of the Cu(II) and Pt (II) complexes. Inorganica Chimica Acta, 504. ISSN 0020-1693
|
Text
Inorg Chim Acta Final Manuscript.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (2MB) | Preview |
Abstract
Mn(II), Cu(II), Zn(II) and Pt(II) complexes of 2-((p-tolylamino)methyl)phenolyldithiocarbamate were synthesized and characterized by elemental analyses and spectroscopic techniques. Spectroscopic studies indicate four coordinate geometry around the metal(II) ions and single crystal X-ray crystallography confirmed the molecular structures of Cu(II) and Pt(II) complexes as distorted square planar. In vitro cytotoxic effects of the complexes, indicative of potential anti-cancer properties, were evaluated using human cancer cell lines HeLa and MRC5-SV2, and a normal cell line, MRC5. The complexes exhibited significant toxicity against the cancer cell lines, with IC50 values of less than 50 µM after 48 h of exposure. Cu(II) and Zn(II) were the most potent and were virtually equipotent in their cytotoxicity against each of the two cancer cells, but only Zn(II) exhibited higher selectivity for a cancer cell than for a normal cell. Mn(II) complex was the least potent, while Pt(II) was the least cancer cell-selective, exhibiting significantly higher toxicity against the parental (normal) MRC-5 cell than against its cancer variant, MRC5-SV2. These compounds could, therefore, inspire the development of inorganic drug leads to generate novel anti-cancer drugs to be delivered directly to the cancerous tissue or through special delivery systems.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 0302 Inorganic Chemistry, 0399 Other Chemical Sciences, 0306 Physical Chemistry (incl. Structural) |
| Subjects: | Q Science > QD Chemistry R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | Elsevier |
| Date Deposited: | 04 May 2020 09:46 |
| Last Modified: | 04 Sep 2021 07:22 |
| DOI or ID number: | 10.1016/j.ica.2020.119431 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/12870 |
 |
View Item |